FEBS Open Bio (2023) https://doi.org/10.1002/2211-5463.13721
Intrabacterial lipid inclusion-associated proteins: A core machinery conserved from saprophyte Actinobacteria to the human pathogen...
FEBS open bio 2022, https://doi.org/10.1002/2211-546
High content quantitative imaging of Mycobacterium tuberculosis responses to acidic microenvironments within human macrophages Aylan, B.;...
Nat Commun 13, 7338 (2022)
Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolism Bussi, C.; Heunis, T.; Pellegrino,...
Febs J (2022) 290: 1563-1582, https://doi.org/10.1111/febs.16645
Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis Barelier, S.; Avellan, R.; Gnawali, G. R.;...
Bioorg. Med. Chem. Lett. 64 (2022) 128692
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and...
Cell Chem Biol (2021), 29(5):883-896.e5
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein...
FEMS Microbiol Rev (2021), DOI: 10.1093/femsre/fuab029
Intrabacterial lipid inclusions in mycobacteria: unexpected key players in survival and pathogenesis? Mallick, I.; Santucci, P.; Poncin,...
Eur J Med Chem (2021) 209: 112908
Lipolytic Enzymes Inhibitors: a new way for Antibacterial Drugs Discovery Cavalier, J.-F.; Spilling, C. D.; Durand, T.; Camoin, L.;...
FEBS Lett. (2020) 594: 79-93
Methyl arachidonyl fluorophosphonate inhibits Mycobacterium tuberculosis thioesterase TesA and globally affects vancomycin susceptibility...
ACS Infect Dis. (2019) 5 (9): 1597-1608
Cyclipostins and Cyclophostin analogs are multi-target inhibitors that impair growth of Mycobacterium abscessus Madani, A.; Ridenour, J....
